Filing Details
- Accession Number:
- 0001127602-22-006985
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-28 14:40:31
- Reporting Period:
- 2022-02-25
- Accepted Time:
- 2022-02-28 14:40:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1795272 | S. Andrew Kitzmiller | 3471 River Hills Drive Cincinnati OH 45244 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-02-25 | 4,028 | $24.87 | 11,528 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $24.8251 to $24.8698. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.